Abstract | OBJECTIVE: The objective was to evaluate the effect of iron supplementation for 6 mo on blood lead (PbB) concentration in populations of premenopausal (PRE-M) and postmenopausal (POST-M) Korean women. METHODS: We conducted a community intervention trial in Asan, Republic of Korea. Of the 137 enrolled women with hemoglobin (Hb) levels lower than 12 g/dL, 37 were PRE-M and 100 were POST-M. Each woman received the equivalent of 9 mg of supplemental iron per day in the form of sodium- iron ethylene-diaminetetra- acetic acid ( NaFeEDTA) syrup for a period of 6 mo. RESULTS: The initial PbB concentrations were 2.56 +/- 0.99 microg/dL (mean +/- SD) for the PRE-M women and 3.27 +/- 1.24 microg/dL for the POST-M women. The differences were statistically significant (P < 0.01). After 6 mo of NaFeEDTA supplementation, the PbB concentration decreased in the POST-M group but no change was observed in the PRE-M group. When age and baseline Hb levels were adjusted for, PbB concentrations decreased by 0.10 and 0.31 microg/dL in the PRE-M and POST-M groups, respectively, and the results were significant using a multivariate model (P = 0.016). Iron status determined by zinc protoporphyrin, transferrin saturation, and Hb improved significantly in both groups, but serum ferritin decreased significantly in the POST-M women (P < 0.001), with no change in the PRE-M group. CONCLUSION: After 6 mo of supplementation with the equivalent of 9 mg of iron/d in the form of NaFeEDTA, the PbB concentrations in Korean women with anemia appeared to depend on their menopausal status.
|
Authors | Hee-Seon Kim, Min-Kyoung Kim, Byung-Kook Lee |
Journal | Nutrition (Burbank, Los Angeles County, Calif.)
(Nutrition)
Vol. 25
Issue 1
Pg. 66-71
(Jan 2009)
ISSN: 0899-9007 [Print] United States |
PMID | 18834721
(Publication Type: Journal Article)
|
Chemical References |
- Ferric Compounds
- Iron Chelating Agents
- Protoporphyrins
- zinc protoporphyrin
- Lead
- Ferritins
- Edetic Acid
- Iron
- Fe(III)-EDTA
|
Topics |
- Administration, Oral
- Adult
- Aged
- Aging
(blood, physiology)
- Anemia, Iron-Deficiency
(blood, drug therapy, epidemiology, prevention & control)
- Dietary Supplements
- Edetic Acid
(administration & dosage, therapeutic use)
- Female
- Ferric Compounds
(administration & dosage, therapeutic use)
- Ferritins
(blood)
- Humans
- Iron
(blood)
- Iron Chelating Agents
(administration & dosage, therapeutic use)
- Korea
(epidemiology)
- Lead
(blood)
- Menopause
(blood)
- Middle Aged
- Nutritional Status
- Prevalence
- Protoporphyrins
(metabolism)
|